ethinyl estradiol tablets articles & resources on Made-in-China.com

Lupin Pharmaceuticals Obtained Final Marketing Approval From FDA for Its Daysee Tablets

Apr 16, 2013

Lupin Pharmaceuticals has obtained final marketing approval from FDA for its Daysee tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.15mg/0.03mg and Ethinyl Estradiol Tablets, USP, 0.01mg). The company commenced the shipment ...

Tags: Lupin, FDA Marketing Approval, Daysee Tablets

The US FDA Has Approved Teva Pharmaceutical Industries' New Drug Application

Apr 2, 2013

The US FDA has approved Teva Pharmaceutical Industries' new drug application (NDA) for Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets as oral contraceptives. Quartette, designed as next generation of extended ...

Tags: Health, Medicine, oral contraceptives

FDA Has Issued Marketing Approval for Oral Contraceptive Medication

Jan 24, 2013

The US FDA has issued marketing approval for Lupin Pharmaceuticals' Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1mg / 0.02mg, the combined oral contraceptive. Levonorgestrel and Ethinyl Estradiol Tablets are the generic equivalent ...

Tags: FDA, Oral Contraceptive Medication, Lupin Pharmaceuticals

Famy Care Has Won Final FDA Approval

Jan 5, 2013

Famy Care has won final FDA approval for abbreviated new drug application (ANDA) of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15mg/0.03mg, generic equivalent to Teva Branded Pharmaceutical Products' Nordette 28 tablets. Mylan ...

Tags: Medicine

Teva Women's Health Has Announced FDA Acceptance of Its Quartette NDA

Dec 7, 2012

Teva Women's Health, a US-based subsidiary of Teva Pharmaceutical Industries, has announced FDA acceptance of its Quartette new drug application (NDA). The company is seeking approval to manufacture and market Quartette ...

Tags: ethinyl estradiol tablets, market Quartette, contraceptive products

Lupin Pharmaceuticals Gained FDA Approval for Norgestimate and Ethinyl Estradiol Tablets

Dec 7, 2012

Lupin Pharmaceuticals has gained FDA approval for its Norgestimate and Ethinyl Estradiol tablets, 0.18mg/0.025mg, 0.215mg/0.025mg, and 0.25mg/0.025mg. Norgestimate and Ethinyl Estradiol tablets are indicated for the prevention of ...

Tags: Lupin Pharmaceuticals, norgestimate and ethinyl estradiol tablets

Glenmark Generics Received Final FDA Approval for Abbreviated New Drug Application

Dec 7, 2012

Glenmark Generics, a US subsidiary of Glenmark Pharmaceuticals, has received final FDA approval for its abbreviated new drug application for Norgestimate and Ethinyl Estradiol tablets USP 0.25mg/0.035mg. The product is the generic version ...

Tags: Glenmark Generics, abbreviated new drug

Glenmark Generics Has Announced a Consumer-Level Recall

Dec 3, 2012

Glenmark Generics has announced a consumer-level recall of seven lots of Norgestimate and Ethinyl Estradiol tablets USP, 0.18mg/0.035mg, 0.215mg/0.035mg, 0.25mg/0.035mg, because of packaging error. Select blisters were rotated 180 ...

Tags: Recall, packaging error, medical product

Branham Law Group Is Investigating Pfizer for Its Recall

Nov 30, 2012

Branham Law Group, a US law firm, is investigating Pfizer for its recall of 14 lots of Lo/Ovral-28 tablet packs and 14 lots of generic Norgestrel and Ethinyl Estradiol tablets. Pfizer manufactured both drugs and they were marketed in ...

Tags: Investigation, recalls, medical industry

Pfizer Has Voluntarily Recalled 14 Lots of Lo/Ovral-28 and 14 Lots of Norgestrel

Nov 30, 2012

Pfizer has voluntarily recalled 14 lots of Lo/Ovral-28 and 14 lots of Norgestrel and Ethinyl Estradiol tablets in the US due to possibility of inexact tablet counts or out of sequence tablets. The products are indicated for the ...

Tags: Recall, tablets packaging error, Contraceptives

ethinyl estradiol tablets

Related Products